XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation - Summary of Stock Options Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]    
Number of Shares, Outstanding | shares 13,632,278  
Number of Shares, Granted | shares 3,766,550  
Number of Shares, Cancelled | shares (392,509)  
Number of Shares, Outstanding | shares 17,006,319 13,632,278
Number of Shares, Vested and expected to vest | shares 17,006,319  
Number of Shares, Vested and exercisable | shares 10,208,053  
Weighted Average Exercise Price Per Share    
Weighted Average Exercise Price Per Share, Outstanding | $ / shares $ 18.48  
Weighted Average Exercise Price Per Share, Granted | $ / shares 4.49  
Weighted Average Exercise Price Per Share, Cancelled | $ / shares 21.46  
Weighted Average Exercise Price Per Share, Outstanding | $ / shares 15.31 $ 18.48
Weighted Average Exercise Price Per Share, Vested and expected to vest | $ / shares 15.31  
Weighted Average Exercise Price Per Share, Vested and exercisable | $ / shares $ 16.37  
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value    
Weighted Average Remaining Contractual Term (years), Outstanding 7 years 4 months 24 days 7 years 8 months 12 days
Weighted Average Remaining Contractual Term (years), Vested and expected to vest 7 years 4 months 24 days  
Weighted Average Remaining Contractual Term (years), Vested and exercisable 6 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding | $ $ 4,913 $ 10,937
Aggregate Intrinsic Value, Vested and expected to vest | $ 4,913  
Aggregate Intrinsic Value, Vested and exercisable | $ $ 4,874